Retention of Neutralizing Response against SARS-CoV-2 Omicron Variant in Sputnik V-Vaccinated Individuals

The new Omicron variant of SARS-CoV-2, first identified in November 2021, is rapidly spreading all around the world. Omicron has become the dominant variant of SARS-CoV-2. There are many ongoing studies evaluating the effectiveness of existing vaccines. Studies on the neutralizing activity of vaccin...

Descripción completa

Detalles Bibliográficos
Autores principales: Lapa, Daniele, Grousova, Daria M., Matusali, Giulia, Meschi, Silvia, Colavita, Francesca, Bettini, Aurora, Gramigna, Giulia, Francalancia, Massimo, Garbuglia, Anna Rosa, Girardi, Enrico, Puro, Vincenzo, Antinori, Andrea, Kovyrshina, Anna V., Dolzhikova, Inna V., Shcheblyakov, Dmitry V., Tukhvatulin, Amir I., Zubkova, Olga V., Gushchin, Vladimir A., Logunov, Denis Y., Naroditsky, Boris S., Vaia, Francesco, Gintsburg, Alexander L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144866/
https://www.ncbi.nlm.nih.gov/pubmed/35632574
http://dx.doi.org/10.3390/vaccines10050817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144866/
https://www.ncbi.nlm.nih.gov/pubmed/35632574
http://dx.doi.org/10.3390/vaccines10050817

Ejemplares similares